Similar articles

• Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.

  Iborra S, Soto M, Carrión J, Alonso C, Requena JM. Iborra S, et al. Vaccine. 2004 Sep 28;22(29-30):3865-76. doi: 10.1016/j.vaccine.2004.04.015. Vaccine. 2004. PMID: 15364433
• T cells that react to the immunodominant Leishmania major LACK antigen prevent early dissemination of the parasite in susceptible BALB/c mice.

  Schilling S, Glaichenhaus N. Schilling S, et al. Infect Immun. 2001 Feb;69(2):1212-4. doi: 10.1128/IAI.69.2.1212-1214.2001. Infect Immun. 2001. PMID: 11160025 Free PMC article.
• Regulatory T cells: mediating compromises between host and parasite.

  Sakaguchi S. Sakaguchi S. Nat Immunol. 2003 Jan;4(1):10-1. doi: 10.1038/ni0103-10. Nat Immunol. 2003. PMID: 12496970 No abstract available.
• New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice.

  Launois P, Himmelrich H, Tacchini-Cottier F, Milon G, Louis JA. Launois P, et al. Microbes Infect. 1999 Jan;1(1):59-64. doi: 10.1016/s1286-4579(99)80015-x. Microbes Infect. 1999. PMID: 10847767 Review. No abstract available.
• Susceptibility to infectious diseases: Leishmania as a paradigm.

  Locksley RM, Pingel S, Lacy D, Wakil AE, Bix M, Fowell DJ. Locksley RM, et al. J Infect Dis. 1999 Mar;179 Suppl 2:S305-8. doi: 10.1086/513843. J Infect Dis. 1999. PMID: 10081500 Review.